News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
749,083 Results
Type
Article (50562)
Company Profile (345)
Press Release (698176)
Section
Business (218423)
Career Advice (2574)
Deals (37729)
Drug Delivery (118)
Drug Development (85546)
Employer Resources (180)
FDA (17055)
Job Trends (16225)
News (369072)
Policy (35454)
Tag
2024 BioCapital Digital (14)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (10)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (9)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2870)
Accelerated approval (2)
Adcomms (26)
Allergies (82)
Alliances (54099)
ALS (83)
Alzheimer's disease (1415)
Antibody-drug conjugate (ADC) (121)
Approvals (17019)
Artificial intelligence (246)
Autoimmune disease (13)
Automation (14)
Bankruptcy (380)
Best Places to Work (12317)
BIOSECURE Act (20)
Biosimilars (103)
Biotechnology (224)
Bladder cancer (56)
Brain cancer (27)
Breast cancer (246)
Cancer (1899)
Cardiovascular disease (148)
Career advice (2149)
Career pathing (32)
CAR-T (144)
Cell therapy (407)
Cervical cancer (13)
Clinical research (68815)
Collaboration (762)
Compensation (408)
Complete response letters (26)
COVID-19 (2794)
CRISPR (38)
C-suite (191)
Cystic fibrosis (103)
Data (1763)
Decentralized trials (2)
Denatured (34)
Depression (46)
Diabetes (239)
Diagnostics (6664)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (113)
Drug pricing (118)
Drug shortages (31)
Duchenne muscular dystrophy (70)
Earnings (89656)
Editorial (33)
Employer branding (22)
Employer resources (157)
Events (120779)
Executive appointments (626)
FDA (18073)
Featured Employer (59)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (668)
Gene editing (98)
Generative AI (25)
Gene therapy (288)
GLP-1 (756)
Government (4825)
Grass and pollen (4)
Guidances (46)
Healthcare (20166)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (105)
Indications (24)
Infectious disease (2924)
Inflammatory bowel disease (138)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (75)
Interviews (446)
IPO (17147)
IRA (51)
Job creations (4371)
Job search strategy (1822)
Kidney cancer (9)
Labor market (27)
Layoffs (503)
Leadership (19)
Legal (8772)
Liver cancer (73)
Lung cancer (275)
Lymphoma (126)
Machine learning (2)
Management (62)
Manufacturing (277)
MASH (61)
Medical device (13993)
Medtech (13998)
Mergers & acquisitions (20983)
Metabolic disorders (648)
Multiple sclerosis (61)
NASH (21)
Neurodegenerative disease (88)
Neuropsychiatric disorders (30)
Neuroscience (1894)
NextGen: Class of 2025 (7148)
Non-profit (4907)
Northern California (2270)
Now hiring (36)
Obesity (359)
Opinion (249)
Ovarian cancer (64)
Pain (82)
Pancreatic cancer (71)
Parkinson's disease (129)
Partnered (20)
Patents (190)
Patient recruitment (85)
Peanut (49)
People (60921)
Pharmaceutical (99)
Pharmacy benefit managers (21)
Phase I (21382)
Phase II (30234)
Phase III (22695)
Pipeline (840)
Podcasts (92)
Policy (122)
Postmarket research (2757)
Preclinical (9077)
Press Release (69)
Prostate cancer (86)
Psychedelics (35)
Radiopharmaceuticals (257)
Rare diseases (375)
Real estate (6634)
Recruiting (68)
Regulatory (23796)
Reports (44)
Research institute (2562)
Resumes & cover letters (416)
Rett syndrome (3)
RNA editing (1)
RSV (43)
Schizophrenia (70)
Series A (123)
Series B (73)
Service/supplier (13)
Sickle cell disease (53)
Southern California (1952)
Special edition (15)
Sponsored (32)
Startups (3965)
State (2)
Stomach cancer (14)
Supply chain (61)
The Weekly (57)
United States (20421)
Vaccines (722)
Venture capitalists (36)
Webinars (13)
Weight loss (263)
Women's health (33)
Worklife (16)
Date
Today (30)
Last 7 days (709)
Last 30 days (3006)
Last 365 days (35752)
2025 (6248)
2024 (36971)
2023 (41919)
2022 (53287)
2021 (57910)
2020 (56652)
2019 (49910)
2018 (37838)
2017 (34746)
2016 (34737)
2015 (40811)
2014 (34506)
2013 (29574)
2012 (31619)
2011 (32254)
2010 (30144)
Location
Africa (905)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (43071)
Australia (7035)
California (5210)
Canada (1798)
China (437)
Colorado (241)
Connecticut (251)
Delaware (117)
Europe (95206)
Florida (764)
Georgia (178)
Idaho (62)
Illinois (513)
India (22)
Indiana (289)
Iowa (7)
Japan (132)
Kansas (102)
Kentucky (26)
Louisiana (8)
Maine (68)
Maryland (820)
Massachusetts (4048)
Michigan (217)
Minnesota (365)
Mississippi (2)
Missouri (79)
Montana (30)
Nebraska (26)
Nevada (55)
New Hampshire (64)
New Jersey (1495)
New Mexico (29)
New York (1491)
North Carolina (973)
North Dakota (8)
Northern California (2270)
Ohio (187)
Oklahoma (14)
Oregon (38)
Pennsylvania (1173)
Puerto Rico (7)
Rhode Island (24)
South America (1296)
South Carolina (16)
South Dakota (1)
Southern California (1952)
Tennessee (87)
Texas (774)
Utah (161)
Virginia (133)
Washington D.C. (58)
Washington State (506)
West Virginia (3)
Wisconsin (54)
749,083 Results for "par pharmaceutical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is expanding its voluntary recall to include seven lots of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulates in the product.
April 22, 2024
·
5 min read
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level.
March 12, 2024
·
4 min read
Press Releases
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
3 min read
Press Releases
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025
·
5 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
12 min read
Pharm Country
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, the “Company”), a clinical stage pharmaceutical company, today announced that management will participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on Thursday, June 27, 2024.
June 20, 2024
·
2 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Bexion Pharmaceuticals, Inc. to Participate in the Jefferies London Healthcare Conference
November 12, 2024
·
2 min read
Press Releases
Virpax Pharmaceuticals, Inc. Announces Pricing of $6 Million Public Offering of Common Stock and Pre-Funded Warrants
January 29, 2025
·
3 min read
1 of 74,909
Next
